NCT06522334 Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
| NCT ID | NCT06522334 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ludwig Boltzmann Institute for Lung Health |
| Condition | Interstitial Lung Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-02-28 |
| Primary Completion | 2034-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-02-28 with a primary completion date of 2034-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death. There are no additional interventions regarding this registry.
Eligibility Criteria
Inclusion Criteria: * diagnosis of interstitial lung disease * written informed consent Exclusion Criteria: * to not comprehend and rightfully judge participation
Frequently Asked Questions
Who can join the NCT06522334 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Interstitial Lung Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06522334 currently recruiting?
Yes, NCT06522334 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ludwig Boltzmann Institute for Lung Health to inquire about joining.
Where is the NCT06522334 trial being conducted?
This trial is being conducted at Vienna, Austria, Vienna, Austria, Vienna, Austria, Vienna, Austria and 1 additional location.
Who is sponsoring the NCT06522334 clinical trial?
NCT06522334 is sponsored by Ludwig Boltzmann Institute for Lung Health. The trial plans to enroll 400 participants.